Abstract |
KIAA1549-BRAF is the most frequently identified genetic mutation in sporadic pilocytic astrocytoma (PA), creating a fusion BRAF (f-BRAF) protein with increased BRAF activity. Fusion-BRAF-expressing neural stem cells (NSCs) exhibit increased cell growth and can generate glioma-like lesions following injection into the cerebella of naïve mice. Increased Iba1+ monocyte (microglia) infiltration is associated with murine f-BRAF-expressing NSC-induced glioma-like lesion formation, suggesting that f-BRAF-expressing NSCs attract microglia to establish a microenvironment supportive of tumorigenesis. Herein, we identify Ccl2 as the chemokine produced by f-BRAF-expressing NSCs, which is critical for creating a permissive stroma for gliomagenesis. In addition, f-BRAF regulation of Ccl2 production operates in an ERK- and NFκB-dependent manner in cerebellar NSCs. Finally, Ccr2-mediated microglia recruitment is required for glioma-like lesion formation in vivo, as tumor do not form in Ccr2-deficient mice following f-BRAF-expressing NSC injection. Collectively, these results demonstrate that f-BRAF expression creates a supportive tumor microenvironment through NFκB-mediated Ccl2 production and microglia recruitment.
|
Authors | Ran Chen, Chanel Keoni, Christopher A Waker, Robert M Lober, Yi-Hsien Chen, David H Gutmann |
Journal | Neoplasia (New York, N.Y.)
(Neoplasia)
Vol. 21
Issue 1
Pg. 52-60
(01 2019)
ISSN: 1476-5586 [Electronic] United States |
PMID | 30504064
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- BRAF-KIAA1549 fusion protein, human
- CCL2 protein, human
- Chemokine CCL2
- NF-kappa B
- Oncogene Proteins, Fusion
|
Topics |
- Animals
- Cell Line, Tumor
- Cell Proliferation
- Chemokine CCL2
(biosynthesis)
- Gene Expression
- Gene Knockdown Techniques
- Humans
- Male
- Mice
- Mice, Transgenic
- NF-kappa B
(metabolism)
- Neoplasms
(genetics, metabolism, pathology)
- Oncogene Proteins, Fusion
(genetics)
- Tumor Microenvironment
(genetics)
|